Cell type-specific anti-human immunodeficiency virus type 1 activity of the transactivation inhibitor Ro5-3335
- PMID: 1282790
- PMCID: PMC245518
- DOI: 10.1128/AAC.36.12.2628
Cell type-specific anti-human immunodeficiency virus type 1 activity of the transactivation inhibitor Ro5-3335
Abstract
The drug Ro5-3335 [7-chloro-5-(2-pyrryl)-3H-1,4-benzodiazepin-2(H)-one] inhibits human immunodeficiency virus type 1 (HIV-1) gene expression at the transcriptional level through interference with Tat-mediated transactivation (M.-C. Hsu, A. D. Schutt, M. Holly, L. W. Slice, M. I. Sherman, D. D. Richman, M. J. Potash, and D. J. Volsky, Science 254:1799-1802, 1991). We confirmed this specific inhibitory effect in a quantitative bioassay based on transactivation of a chimeric gene comprising the HIV-1 long terminal repeat promoter fused to the lacZ gene of Escherichia coli and transfected in a HeLa cell line expressing Tat. Ro5-3335 was found to inhibit HIV-1 long terminal repeat-driven lacZ gene expression at a 50% inhibitory concentration of 0.5 microM. The in vitro anti-HIV-1 activity of Ro5-3335 was highly dependent on the nature of the host cells. The highest selectivity index, 50, was found in phytohemagglutinin-stimulated peripheral blood lymphocytes. The selectivity index was between 1 and 10 in the CD4+ T-cell lines CEM, MOLT-4 (clone 8), and HUT-78. In MT-4 and MT-2 cells, Ro5-3335 had no inhibitory effect on HIV-1 replication. The absence of anti-HIV-1 activity of Ro5-3335 in MT-4 cells was confirmed by using different parameters of virus replication and different multiplicities of infection. In persistently HIV-1-infected HUT-78/IIIB/LAI cells, Ro5-3335 failed to demonstrate any activity at subtoxic concentrations. The cytotoxicity of Ro5-3335 was significantly lower in peripheral blood lymphocytes than in the CD4+ T-cell lines.
Similar articles
-
Differential effect of tumor necrosis factor-alpha and herpes simplex virus type 1 on the Tat-targeted inhibition of human immunodeficiency virus type 1 replication.Virology. 1994 Aug 1;202(2):521-9. doi: 10.1006/viro.1994.1374. Virology. 1994. PMID: 8030218
-
2-Glycineamide-5-chlorophenyl 2-pyrryl ketone, a non-benzodiazepin Tat antagonist, is effective against acute and chronic HIV-1 infections in vitro.Antiviral Res. 1996 Oct;32(2):55-62. doi: 10.1016/0166-3542(95)00980-9. Antiviral Res. 1996. PMID: 8891164
-
Inhibition of HIV replication in acute and chronic infections in vitro by a Tat antagonist.Science. 1991 Dec 20;254(5039):1799-802. doi: 10.1126/science.1763331. Science. 1991. PMID: 1763331
-
Inhibition of human immunodeficiency virus type 1 Tat-dependent activation of translation in Xenopus oocytes by the benzodiazepine Ro24-7429 requires trans-activation response element loop sequences.J Virol. 1994 Jan;68(1):25-33. doi: 10.1128/JVI.68.1.25-33.1994. J Virol. 1994. PMID: 8254735 Free PMC article.
-
The human immunodeficiency virus type 1 Tat antagonist, Ro 5-3335, predominantly inhibits transcription initiation from the viral promoter.J Virol. 1995 Apr;69(4):2640-3. doi: 10.1128/JVI.69.4.2640-2643.1995. J Virol. 1995. PMID: 7884917 Free PMC article.
Cited by
-
SRR-SB3, a disulfide-containing macrolide that inhibits a late stage of the replicative cycle of human immunodeficiency virus.Antimicrob Agents Chemother. 1997 Feb;41(2):262-8. doi: 10.1128/AAC.41.2.262. Antimicrob Agents Chemother. 1997. PMID: 9021177 Free PMC article.
-
Strategies to Block HIV Transcription: Focus on Small Molecule Tat Inhibitors.Biology (Basel). 2012 Nov 19;1(3):668-97. doi: 10.3390/biology1030668. Biology (Basel). 2012. PMID: 24832514 Free PMC article.
-
Targeting binding partners of the CBFβ-SMMHC fusion protein for the treatment of inversion 16 acute myeloid leukemia.Oncotarget. 2016 Oct 4;7(40):66255-66266. doi: 10.18632/oncotarget.11357. Oncotarget. 2016. PMID: 27542261 Free PMC article. Review.
-
Potent and selective inhibition of human immunodeficiency virus type 1 transcription by piperazinyloxoquinoline derivatives.Antimicrob Agents Chemother. 1997 Jun;41(6):1250-5. doi: 10.1128/AAC.41.6.1250. Antimicrob Agents Chemother. 1997. PMID: 9174179 Free PMC article.
-
An autoregulated dual-function antitat gene for human immunodeficiency virus type 1 gene therapy.J Virol. 1995 Jan;69(1):206-12. doi: 10.1128/JVI.69.1.206-212.1995. J Virol. 1995. PMID: 7983711 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials